| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/17/2024 | $20.00 | Neutral | Analyst |
| 11/6/2024 | $22.00 → $19.00 | Buy → Neutral | BofA Securities |
| 10/11/2024 | $24.00 | Overweight | KeyBanc Capital Markets |
| 8/12/2024 | $22.00 | Buy | BofA Securities |
| 8/12/2024 | $18.00 | Buy | Loop Capital |
| 8/12/2024 | $24.00 | Overweight | Stephens |
| 8/12/2024 | $21.00 | Buy | Citigroup |
| 8/12/2024 | $23.00 | Outperform | RBC Capital Mkts |
| 8/12/2024 | $27.00 | Overweight | Morgan Stanley |
| 8/12/2024 | $18.00 | Neutral | JP Morgan |
4 - Ardent Health Partners, Inc. (0001756655) (Issuer)
4 - Ardent Health Partners, Inc. (0001756655) (Issuer)
3 - Ardent Health Partners, Inc. (0001756655) (Issuer)
4 - Ardent Health Partners, Inc. (0001756655) (Issuer)
3 - Ardent Health Partners, Inc. (0001756655) (Issuer)
4 - Ardent Health Partners, Inc. (0001756655) (Issuer)
4 - Ardent Health Partners, Inc. (0001756655) (Issuer)
4 - Ardent Health Partners, Inc. (0001756655) (Issuer)
4 - Ardent Health Partners, Inc. (0001756655) (Issuer)
4 - Ardent Health Partners, Inc. (0001756655) (Issuer)
4 - Ardent Health Partners, Inc. (0001756655) (Issuer)
Analyst resumed coverage of Ardent Health Partners with a rating of Neutral and set a new price target of $20.00
BofA Securities downgraded Ardent Health Partners from Buy to Neutral and set a new price target of $19.00 from $22.00 previously
KeyBanc Capital Markets initiated coverage of Ardent Health Partners with a rating of Overweight and set a new price target of $24.00
BofA Securities initiated coverage of Ardent Health Partners with a rating of Buy and set a new price target of $22.00
Loop Capital initiated coverage of Ardent Health Partners with a rating of Buy and set a new price target of $18.00
Stephens initiated coverage of Ardent Health Partners with a rating of Overweight and set a new price target of $24.00
Citigroup initiated coverage of Ardent Health Partners with a rating of Buy and set a new price target of $21.00
RBC Capital Mkts initiated coverage of Ardent Health Partners with a rating of Outperform and set a new price target of $23.00
Morgan Stanley initiated coverage of Ardent Health Partners with a rating of Overweight and set a new price target of $27.00
JP Morgan initiated coverage of Ardent Health Partners with a rating of Neutral and set a new price target of $18.00
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Robert A. DeMichiei to its board of directors. A seasoned leader with over 30 years of experience in financial strategy, healthcare operations, and board governance, Mr. DeMichiei served as executive vice president and chief financial officer at the University of Pittsburgh Medical Center (UPMC) from 2004 to 2020. During his tenure, he played a pivotal role in driving UPMC's financial growth and led numerous strategic initiatives, including mergers and acquisitions, supply chain management, and revenue cycle improvements. Prior to joining U
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Dave Caspers as chief operating officer. In this new role, Caspers will oversee operations across Ardent Health, which includes 30 hospitals and 280 sites of care in six states. He will be responsible for executing on strategic growth initiatives and driving operational excellence at an enterprise level. Caspers will also lead efforts to further optimize and scale the company's consumer-centric operating model across new and existing markets. "We are pleased to welcome Dave to Ardent," said Ardent Health President and CEO Marty Bonick. "His
Ardent Health (NYSE:ARDT) today announced the appointment of Dave Styblo as senior vice president of investor relations. In his new role, Styblo will oversee Ardent's investor relations program and serve as the primary liaison with investors, analysts and financial partners. Styblo brings more than 20 years of investment experience, including time as a sell-side analyst covering the healthcare industry. He previously served as a senior vice president at Jefferies for more than a decade as an equity research analyst with a focus on healthcare services and managed care stocks. Most recently, Styblo served as an independent investor relations advisor to healthcare companies. He began his c
Ardent Health Partners, Inc. (NYSE:ARDT) ("Ardent Health" or the "Company"), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced results for the quarter ended March 31, 2025. First Quarter 2025 Operating and Financial Summary All comparisons are versus the same prior year period. See the footnotes to the Operating Statistics table of this press release for definitions of the metrics below and a full list of key operating metrics. Total Revenue $1.50 billion 4.0% growth Y/Y Net Income Attributable to Ardent Health $41 million Adjusted EBITDA(1) $98 million 2.5% growth Y/Y Adjusted EBITDAR(1) $139 million
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that members of the Company's management team will participate in the following upcoming investor conferences: Bank of America Securities 2025 Health Care Conference on May 13 and 14, 2025, in Las Vegas, Nevada. Members of the management team will participate in a presentation at 11:40 a.m. ET on Wednesday, May 14, 2025. 2025 RBC Capital Markets Global Healthcare Conference on Tuesday, May 20, 2025, in New York City, New York. Members of the management team will participate in a fireside chat at 8:00 a.m. ET that same day. A live audio webcast of these p
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that seven of its facilities earned an "A" Hospital Safety Grade from The Leapfrog Group, an independent national nonprofit watchdog focused on patient safety. Leapfrog assigns an "A," "B," "C," "D" or "F" grade to general hospitals across the country based on over 30 measures of errors, accidents, injuries and infections as well as the systems hospitals have in place to prevent them. "At Ardent, safety is our highest priority, ensuring the well-being of every patient, team member and visitor in our care," said Ardent Health President and CEO Marty Bonick. "Th
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it will issue its first quarter 2025 results after the market closes on Tuesday, May 6, 2025. A conference call will be held the following day, Wednesday, May 7, 2025, at 10:00 a.m. ET to review the Company's financial results, discuss recent events and conduct a question-and-answer session. A webcast of the conference call and accompanying presentation materials will be available in the Investor Relations section of Ardent's website at ir.ardenthealth.com. To listen to a live broadcast, go to the site at least 15 minutes prior to the scheduled start time
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Robert A. DeMichiei to its board of directors. A seasoned leader with over 30 years of experience in financial strategy, healthcare operations, and board governance, Mr. DeMichiei served as executive vice president and chief financial officer at the University of Pittsburgh Medical Center (UPMC) from 2004 to 2020. During his tenure, he played a pivotal role in driving UPMC's financial growth and led numerous strategic initiatives, including mergers and acquisitions, supply chain management, and revenue cycle improvements. Prior to joining U
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Dave Caspers as chief operating officer. In this new role, Caspers will oversee operations across Ardent Health, which includes 30 hospitals and 280 sites of care in six states. He will be responsible for executing on strategic growth initiatives and driving operational excellence at an enterprise level. Caspers will also lead efforts to further optimize and scale the company's consumer-centric operating model across new and existing markets. "We are pleased to welcome Dave to Ardent," said Ardent Health President and CEO Marty Bonick. "His
Ardent Health Partners, Inc. (NYSE:ARDT) ("Ardent Health" or the "Company"), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced results for the fourth quarter and year ended December 31, 2024. Fourth Quarter 2024 Operating and Financial Summary All comparisons are versus the same prior year period. See the footnotes to the Operating Statistics table of this press release for definitions of the metrics below and a full list of key operating metrics. Total Revenue $1.61 billion 19% growth Y/Y Net Income Attributable to Ardent Health $114 million Adjusted EBITDA(1) $183 million 213% growth Y/Y
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that members of the Company's management team will participate in the following investor conferences: Leerink Partners Global Healthcare Conference on Monday, March 10, 2025, in Miami, Florida. Members of the management team will participate in a fireside chat discussion at 8 a.m. ET that same day. KeyBanc Capital Markets Healthcare Forum on Wednesday, March 19, 2025. Members of the management team will participate in a fireside chat discussion at 9 a.m. ET that same day. A live audio webcast of these presentations will be available at the Investor Rel
Newly appointed President Walter D. Conwell, MD, MBA, poised to broaden reach with healthcare organizations nationwide Two board members bring additional expertise in health equity innovation and regulation Leadership team committed to TruLite's exponential growth potential as only health equity solution addressing clinical bias at point of care TruLite Health, developer of the only health equity solution to remediate clinical bias, has expanded the leadership team as the company strengthens artificial intelligence capabilities and scales to meet the needs of hospital systems, educational institutions and other healthcare organizations nationwide. Walter D. Conwell, MD, MBA, now ser
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it will issue its fourth quarter and full year 2024 results after the market closes on Wednesday, February 26, 2025. A conference call will be held the following day, Thursday, February 27, 2025, at 9:00 a.m. ET to review the Company's financial results, discuss recent events and conduct a question-and-answer session. A webcast of the conference call and accompanying presentation materials will be available in the Investor Relations section of Ardent's website at ir.ardenthealth.com. To listen to a live broadcast, go to the site at least 15 minutes prior
Ardent Health Partners, Inc. (NYSE:ARDT) ("Ardent Health" or the "Company"), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced results for the quarter ended March 31, 2025. First Quarter 2025 Operating and Financial Summary All comparisons are versus the same prior year period. See the footnotes to the Operating Statistics table of this press release for definitions of the metrics below and a full list of key operating metrics. Total Revenue $1.50 billion 4.0% growth Y/Y Net Income Attributable to Ardent Health $41 million Adjusted EBITDA(1) $98 million 2.5% growth Y/Y Adjusted EBITDAR(1) $139 million
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it will issue its first quarter 2025 results after the market closes on Tuesday, May 6, 2025. A conference call will be held the following day, Wednesday, May 7, 2025, at 10:00 a.m. ET to review the Company's financial results, discuss recent events and conduct a question-and-answer session. A webcast of the conference call and accompanying presentation materials will be available in the Investor Relations section of Ardent's website at ir.ardenthealth.com. To listen to a live broadcast, go to the site at least 15 minutes prior to the scheduled start time
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it will issue its fourth quarter and full year 2024 results after the market closes on Wednesday, February 26, 2025. A conference call will be held the following day, Thursday, February 27, 2025, at 9:00 a.m. ET to review the Company's financial results, discuss recent events and conduct a question-and-answer session. A webcast of the conference call and accompanying presentation materials will be available in the Investor Relations section of Ardent's website at ir.ardenthealth.com. To listen to a live broadcast, go to the site at least 15 minutes prior
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced it has acquired 18 urgent care clinics across New Mexico and Oklahoma from NextCare Urgent Care. "Expanding our urgent care footprint represents significant progress in our mission to create a consumer-focused ecosystem of care in each of the communities we serve," said Ardent Health President and CEO Marty Bonick. "We're helping patients receive the care they need, when and where they need it, by increasing access to convenient, high-quality services. These additional access points also bring new patients into our network while creating enhanced capacity to
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing midsize urban communities across the U.S., today announced it will issue its third quarter 2024 results after the market closes on Wednesday, November 6, 2024. A conference call will be held the following day, Thursday, November 7, 2024, at 9:00 a.m. ET to review the Company's financial results, discuss recent events and conduct a question-and-answer session. A webcast of the conference call and accompanying presentation materials will be available in the Investor Relations section of Ardent's website at https://ir.ardenthealth.com. To listen to a live broadcast, go to the site at least 15 minutes prior to the scheduled
Ardent Health Partners, Inc. (NYSE:ARDT) ("Ardent Health" or the "Company"), a leading provider of healthcare in growing midsize urban communities across the U.S., today announced that it will issue its second quarter 2024 results after the market closes on Wednesday, August 14, 2024. A conference call will be held the following day, Thursday, August 15, 2024, at 10:00 a.m. ET to review the Company's financial results, discuss recent events and conduct a question-and-answer session. A webcast of the conference call and accompanying presentation materials will be available in the Investor Relations section of Ardent's website at https://ir.ardenthealth.com. To listen to a live broadcast, g
10-Q - Ardent Health Partners, Inc. (0001756655) (Filer)
8-K - Ardent Health Partners, Inc. (0001756655) (Filer)
DEFA14A - Ardent Health Partners, Inc. (0001756655) (Filer)
DEF 14A - Ardent Health Partners, Inc. (0001756655) (Filer)
8-K - Ardent Health Partners, Inc. (0001756655) (Filer)
8-K - Ardent Health Partners, Inc. (0001756655) (Filer)
10-K - Ardent Health Partners, Inc. (0001756655) (Filer)
8-K - Ardent Health Partners, Inc. (0001756655) (Filer)
8-K - Ardent Health Partners, Inc. (0001756655) (Filer)
8-K - Ardent Health Partners, Inc. (0001756655) (Filer)
SC 13G - Ardent Health Partners, Inc. (0001756655) (Subject)
SC 13G - Ardent Health Partners, Inc. (0001756655) (Subject)
SC 13G - Ardent Health Partners, Inc. (0001756655) (Subject)